Because uptake of allergens and haptens is a strong inducer of AD and it was shown in mice that hapten-induced dermatitis results in decreased Cldn-1 levels and opening of TJs3 it would be interesting to test the interaction of allergens/haptens and different Cldn-1 levels in future in human keratinocyte models. This evidence concerns the gene CLDN1 and Alzheimer disease.